Neuroprotection of paclitaxel against cerebral ischemia/reperfusion-induced brain injury through JNK3 signaling pathway

Journal of Receptors and Signal Transduction

Volumn 31, Issue 6, 2011, Pages 402-407

  Qi, Su Hua ^a   Zhao, Hui ^b,c   Gong, Juan Juan ^a   Sun, Fu Mou ^d   Yue, Jun ^a   Guan, Qiu Hua ^a   Wang, Min ^d  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c XUZHOU CENTRAL HOSPITAL   (China)

^d CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

C Jun N terminal kinase 3 (JNK3); Caspase 3; Cerebral ischemia; Neuroprotection; Paclitaxel

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 10; MIXED LINEAGE KINASE 3; NEUROPROTECTIVE AGENT; PACLITAXEL; PROTEIN BCL 2; PROTEIN C JUN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN ISCHEMIA; CASPASE 3; CELL DEATH; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 10; NEURONS; NEUROPROTECTIVE AGENTS; PACLITAXEL; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUBULIN MODULATORS;

EID: 80955142406     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2011.621070     Document Type: Article

References (21)

1. Irving EA, Bamford M. Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 2002, 22, 631-647. (Pubitemid 34596455)
2. Maroney AC, Glicksman MA, Basma AN, Walton KM, Knight E Jr, Murphy CA, Bartlett BA, Finn JP, Angeles T, Matsuda Y, Neff NT, Dionne CA. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci 1998, 18, 104-111. (Pubitemid 28046771)
3. Watson A, Eilers A, Lallemand D, Kyriakis J, Rubin LL, Ham J. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J Neurosci 1998, 18, 751-762. (Pubitemid 28041911)
4. Tian H, Zhang G, Li H, Zhang Q. Antioxidant NAC and AMPA/KA receptor antagonist DNQX inhibited JNK3 activation following global ischemia in rat hippocampus. Neurosci Res 2003, 46, 191-197. (Pubitemid 36593282)
5. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270, 1326-1331.
6. Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 1997, 389, 865-870. (Pubitemid 27462982)
7. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103, 239-252.
8. Tibbles LA, Ing YL, Kiefer F, Chan J, Iscove N, Woodgett JR, LassamNJ. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J 1996, 15, 7026-7035. (Pubitemid 27023273)
9. Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev 1997, 7, 67-74.
10. Guan QH, Pei DS, Zhang QG, Hao ZB, Xu TL, Zhang GY. The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways. Brain Res 2005, 1035, 51-59.
11. Pan J, Zhang QG, Zhang GY. The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region. Neuroscience 2005, 131, 147-159. (Pubitemid 40170496)
12. Pei DS, Wang XT, Liu Y, Sun YF, Guan QH, Wang W, Yan JZ, Zong Y, Xu TL, Zhang GY. Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence. Brain 2006, 129, 465-479. (Pubitemid 43164369)
13. Rowinsky EK, Chaudhry V, Cornblath DR, Donehower RC. Neurotoxicity of Taxol. J Natl Cancer Inst Monographs 1993, 15, 107-115.
14. Masurovsky EB, Peterson ER, Crain SM, Horwitz SB. Morphological alterations in dorsal root ganglion neurons and supporting cells of organotypic mouse spinal cord-ganglion cultures exposed to taxol. Neuroscience 1983, 10, 491-509. (Pubitemid 13019583)
15. Guibin L, Alexander F, Brandon JT, Sung OY, Gunda G, Mary LM, Rick TD. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases b-amyloid toxicity in cortical neurons, J Neurochem 2003, 84, 347-362.
16. Michaelis ML, Ranciat N, Chen Y, Bechtel M, Ragan R, Hepperle M, Liu Y, Georg G. Protection against beta-amyloid toxicity in primary neurons by paclitaxel (Taxol). J Neurochem 1998, 70, 1623-1627. (Pubitemid 28136977)
17. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001, 81, 741-766.
18. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979, 10, 267-272. (Pubitemid 9141527)
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193, 265-275.
20. Zheng Z, Zhao H, Steinberg GK, Yenari MA. Cellular and molecular events underlying ischemia-induced neuronal apoptosis. Drug News Perspect 2003, 16, 497-503. (Pubitemid 37484368)
21. Kuan CY, Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, Bao J, Banasiak KJ, Haddad GG, Flavell RA, Davis RJ, Rakic P. A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci USA 2003, 100, 15184-15189. (Pubitemid 37518037)